60% of high-priority research goes unfunded.
Treatment of metastatic parathyroid cancer
The following are treatment options for metastatic parathyroid cancer. The types of treatments given are based on the unique needs of the person with cancer.
Surgery may be offered for metastatic parathyroid cancer to remove:
- bring calcium in the blood to normal levels before surgery
- control hypercalcemia in people with disease that cannot be removed by surgery (unresectable disease)
Cinacalcet is a medication used alone or with other drugs to treat hypercalcemia in recurrent or metastatic parathyroid cancer (it is not used to treat other forms of hypercalcemia). This drug is in a class of medications called calcimimetics. It works by signalling the body to produce less parathyroid hormone, which in turn decreases the amount of calcium in the blood.
Radiation therapy may be offered for metastatic parathyroid cancer. External beam radiation therapy may be given for:
- local metastases in the neck (if surgery is not an option)
- distant metastases to the lungs, liver or bones
Chemotherapy may be offered for metastatic parathyroid cancer when the cancer cannot be completely removed by surgery. The types of chemotherapy are:
- dacarbazine (DTIC) alone
- drug combinations
- 5-fluorouracil (Adrucil, 5-FU), cyclophosphamide (Cytoxan, Procytox) and paclitaxel (Taxol)
- 5-fluorouracil, cyclophosphamide and dacarbazine
People with parathyroid cancer may be offered the opportunity to participate in clinical trials. For more information, go to clinical trials.
Funding world-class research
Cancer affects all Canadians but together we can reduce the burden by investing in research and prevention efforts. Learn about the impact of our funded research.